Functionalized N,N-dialkylamino phenyl ethers and their method of use

A compound having formula (I):

• Including enantiomers, diastereomers, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, wherein:
• R1 is selected from the group consisting of hydrogen, C1-C6 linear alkyl, C1-C10 branched alkyl, alkenyl, alkynyl, C3-C10 cycloalkyl, cycloalkenyl, alkyl-cycloalkyl and alkyl-cycloalkenyl optionally substituted with a C1-C5 alkyl group;
• R2 is at each occurrence independently selected from the group consisting of H, OH, halogen, CN, NO2, C1-C10 alkoxy, C3-C10 branched alkoxy, C1-C10 haloalkoxy, C3-C10 branched haloalkoxy, NR8R9, C(O)OR10, C1-C10 thioalkyl, C3-C10 branched thioalkyl, C1-C10 halothioalkyl, —S(O)C1-C10 alkyl, —S(O)C3-C10 branched alkyl, —S(O)C1-C10 haloalkyl, —S(O)C3-C10 branched haloalkyl, —SO2C1-C10 alkyl, —SO2C3-C10 branched alkyl, —SO2C1-C10 haloalkyl, —SO2C1-C10 branched haloalkyl, SO2NR11R12, —NR11SO2R13, C(O)—NR11R12;
• R3 is a substituted or unsubstituted aryl or heteroaryl group of 1-10 carbon atoms, wherein the heteroaryl group comprises 1-4 heteroatoms, wherein the heteroatom is selected from the group consisting of O, N, S, S(O), SO2, and wherein the aryl or heteroaryl group may be optionally substituted with a substituent selected from the group consisting of H, OH, halogen, CN, NO2, C1-C10 alkoxy, C3-C10 branched alkoxy, C1-C10 haloalkoxy, C3-C10 branched haloalkoxy, NR8R9, C(O)OR10, C1-C10 thioalkyl, C3-C10 branched thioalkyl, C1-C10 halothioalkyl, —S(O)C1-C10 alkyl, —S(O)C3-C10 branched alkyl, —S(O)C1-C10 haloalkyl, —S(O)C3-C10 branched haloalkyl, —SO2C1-C10 alkyl, —SO2C3-C10 branched alkyl, —SO2C1-C10 haloalkyl, —SO2C1-C10 branched haloalkyl, SO2NR11R12, —NR11SO2R13, C(O)—NR11R12;
• R4 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• R5 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• m is 2, 3, 4, 5, 6, 7, 8, 9, or 10;
• R6 is selected from the group consisting of hydrogen, C1-C6 linear alkyl and C3-C7 branched alkyl;
• R7 is selected from the group consisting of hydrogen, C1-C6 linear alkyl and C3-C7 branched alkyl;
• or R6 and R7 may optionally be taken together with the atoms to which they are bound to form a ring containing 4 to 7 members, and wherein the ring may optionally comprise a member selected from the group consisting of O, S, and NR14;
• R8 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• R9 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• R10 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• R11 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• R12 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• R13 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl;
• and
• R14 is at each occurrence independently selected from the group consisting of hydrogen, C1-C6 linear alkyl, and C3-C7 branched alkyl.